Evidence map›Paper›PMID 41843138›Full record

ReviewArchives of microbiology2026

From structure to design: experimental and AI-driven approaches in receptor-binding protein engineering for reprogramming phage host range.

Shuo Xu, Shuqi Yang, Xin Jiao, Jiaqi Cai, Jiahui Wu, Jinjuan Qiao

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shuo XuSchool of Medical Laboratory, Shandong Second Medical University, Weifang, 261053, Shandong, PR China.
Shuqi YangSchool of Medical Laboratory, Shandong Second Medical University, Weifang, 261053, Shandong, PR China.
Xin JiaoSchool of Medical Laboratory, Shandong Second Medical University, Weifang, 261053, Shandong, PR China.
Jiaqi CaiSchool of Medical Laboratory, Shandong Second Medical University, Weifang, 261053, Shandong, PR China.
Jiahui WuSchool of Medical Laboratory, Shandong Second Medical University, Weifang, 261053, Shandong, PR China.
Jinjuan QiaoSchool of Medical Laboratory, Shandong Second Medical University, Weifang, 261053, Shandong, PR China. qiaojj@sdsmu.edu.cn.

Funding

Graduate Student Research Grant from Shandong Second Medical University 2025YJSCX014the College Students' Innovation and Entrepreneurship Training Program of Shandong Province Grant No. S202510438012the National Natural Science Foundation of China Grant No. 82502771the Natural Science Foundation of Shandong Province, China Grant No. ZR2020MH305
6 · The paper itself

Abstract

The emerging crisis of antimicrobial resistance has renewed interest in bacteriophage (phage) therapy as a promising alternative. The efficacy of phage therapy primarily depends on the specific interaction between the phage’s receptor-binding proteins (RBPs) and receptors on the bacterial surface. RBPs are critical for host recognition and infection, and engineering RBPs to alter host range and tropism is a key strategy for improving phage-based treatments. Recently, artificial intelligence (AI)-based tools have emerged as enabling technologies for protein engineering, ranging from predicting RBP structures using tools like AlphaFold to optimizing binding interactions through directed evolution, chimeric design, and deep learning-assisted host range prediction. In this review, we summarize the distinct structural features of RBPs and the main engineering strategies employed to modify them. We further evaluate the application of AI-driven approaches in RBP engineering, discussing current methodologies, including structure prediction, directed evolution, and deep learning-assisted host range prediction, along with current challenges such as data scarcity, model interpretability, bottlenecks in high-throughput experimental validation, and biosafety and ethical concerns. Finally, we outline future directions for leveraging the integration of experimental and AI-driven approaches to advance the rational design of next-generation phage therapeutics with tailored host specificity and improved efficacy against multidrug-resistant bacterial infections.

Indexed as

Artificial IntelligenceBacteriophagesHost SpecificityProtein EngineeringPhage TherapyArtificial intelligenceBacteriophageHost rangeProtein engineeringReceptor-binding protein

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.